Tony Hunter

Tony Hunter

Company: Salk Institute

Job title: Professor


Will Histidine Phosphorylation Make a Good Drug Target? 8:30 am

Overcoming difficulties of studying labile phosphorylations to widen the therapeutic targeting of kinases and with non-canonical phosphorylations Harnessing novel tools to study the functions behind histidine phosphorylation in normal and cancer cells, and the possibility for reversible post-translational modification for cell regulation Discussing the prospects for targeting histidine phosphorylation therapeutically with small moleculesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.